James J. Dignam to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications James J. Dignam has written about Antimetabolites, Antineoplastic.
Connection Strength
0.024
-
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res. 2005 Dec 01; 65(23):10692-9.
Score: 0.015
-
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1997 Nov 19; 89(22):1673-82.
Score: 0.009